FDA Drug Application (021779) for VENTAVIS by ACTELION PHARMS LTD

Back to FDA Applications sponsored by ACTELION PHARMS LTD

Application Number021779
Product Number001
FormSOLUTION;INHALATION
Dosage20MCG/2ML (10MCG/ML)
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameVENTAVIS
Active IngredientILOPROST



Back to FDA Applications sponsored by ACTELION PHARMS LTD